| Shareholder | |||||
|---|---|---|---|---|---|
Jonathan LimCo-Founder, Chairman & CEO | 9.32% | 32.36M | 1.09% | +0 | |
Frazier Life Sciences Management, LP | 7.05% | 24.68M | 0.94% | +1.95M | |
T. Rowe Price Group, Inc. | 6.60% | 23.07M | 0.89% | +6.86M | |
BlackRock, Inc. | 6.05% | 21.15M | 0.44% | +1.00M | |
VR Management, LLC | 4.64% | 16.22M | 0.63% | -166.60K | |
RTW Investments, LP | 4.62% | 16.16M | 4.57% | +16.01M | |
Vanguard Capital Management, LLC | 3.75% | 13.10M | 0.37% | +312.54K | |
Novartis AG | 3.55% | 12.31M | 0.79% | +0 | |
State Street Investment Management | 3.48% | 12.18M | 0.49% | +2.88M | |
Vivo Capital, LLC | 3.47% | 12.15M | 0.21% | +2.88M | |
Artal Group S.A. | 3.26% | 11.40M | 0.36% | +153.54K | |
Logos Global Management, L.P. | 3.19% | 11.15M | 1.39% | -1.85M | |
Paradigm Biocapital Advisors LP | 2.97% | 10.39M | 2.01% | -3.77M | |
Arch Venture Partners, L.P. | 2.03% | 7.09M | 1.86% | -3.96M | |
Geode Capital Management, LLC | 1.86% | 6.50M | 0.07% | +505.28K | |
Cormorant Asset Management, LP | 1.66% | 5.80M | -- | +5.80M | |
Affinity Asset Advisors, LLC | 1.50% | 5.25M | 0.22% | -100.00K | |
Balyasny Asset Management L.P. | 1.47% | 5.14M | 1.44% | +5.05M | |
Janus Henderson Group Ltd. | 1.06% | 3.71M | -- | +3.71M | |
5AM Venture Management, LLC | 1.00% | 3.49M | 0.91% | -1.92M |
